Phase III
A weekly podcast exploring medicine 4.0 as we launch into the 21st Century of health. Join us as we highlight the science and investment case for the different diseases and conditions that life sciences companies are trying to diagnose and cure.
Podcasting since 2024 • 15 episodes
Phase III
Latest Episodes
VAXXED: Game on, with BASE and WEHI
Cancer vaccines are an area that anyone who is anyone is getting into, but it's a field led largely by academics, not-for–profits, and specialist researchers. So this week we go back to basics - science that is. Australia may ...
•
Season 3
•
Episode 4
•
26:07
VAXXED: Boom or bust? With Chris Kallos and Pitt Street Research
In some ways, cancer vaccines are a history of hype and hope, over success. But that hasn't stopped people from trying. In 2024, biotech CEOs are hoping that this time, it's different. Research houses are predicting significant market g...
•
Season 3
•
Episode 3
•
18:30
VAXXED: Deadly infection, with Imugene and ImmVirX
Cancer vaccines are a very niche section of cancer treatments. But two companies in Australia – the only two so far to go public with their work in this arena –are working on an even niche area within this. And one says their work is not a vacc...
•
Season 3
•
Episode 2
•
23:13
VAXXED: From Gardasil to mRNA, with Dr Ian Frazer and Wilsons Advisory
Cancer vaccines started out as prevention. Think Gardasil for cervical and oral cancers caused by HPV, and the hepatitis B vaccine for liver cancer.But today the science has moved on, to therapy vaccines. Vaccines that take immune cells...
•
Season 3
•
Episode 1
•
28:39
NUKED: Our nuclear future, with Novartis, Wilsons Advisory and Cyclotek
Drone-deliveries of radioactive medicines and diagnostics to Australia's far-flung towns. Radiopharmaceuticals matched with genetic information to tailor precisely the right dose and isotope to a person's cancer. Pan-cancer drugs that fix many ...
•
Season 2
•
Episode 6
•
34:16
